Matches in SemOpenAlex for { <https://semopenalex.org/work/W1998318442> ?p ?o ?g. }
Showing items 1 to 92 of
92
with 100 items per page.
- W1998318442 endingPage "42" @default.
- W1998318442 startingPage "37" @default.
- W1998318442 abstract "Introduction. Non-small cell lung cancer (NSCLC) accounts for about 70-80% of all lung cancers. In comparison with small cell lung cancer, NSCLC has relatively low therapy response. Discovery of neuroendocrine markers within the NSCLC group (10-30%) has initiated the issue of their importance in the therapy and prognosis. Objective. The aim of this study was to determine the influence of neuroendocrine differentiation on treatment response and survival in patients with advanced NSCLC. Methods. A clinical trial included 236 patients (73.7% males), with diagnosis of NSCLC, determined by histological verification. These patients were treated by combined chemo- and X-ray therapy at stage III (without pleural effusion) or chemotherapy only at stage III (with pleural effusion) and stage IV of NSCLC. When the progression had been noted at the stage III (without pleural effusion), the treatment was continued with X-ray therapy. Neuron-specific enolase (NSE), chromogranin A (ChrA) as well as synapthophysin (SYN) expression in tissue examples was determined by immunohistochemical analysis with monoclonal mouse anti human bodies (DAKO Comp, Denmark). The treatment was conducted during 4 to 6 chemotherapeutic cycles. The efficacy was assessed after the therapy regimen; median survival time was assessed after the randomization. Results. NSE, ChrA and SYN expression were noted in 56 (23.7%), 33 (13.9%) and 39 (16.5%) patients, respectively. Better therapeutic response was significantly higher in patients with expression of NSE, ChrA and SYN (p<0.05). There was significant correlation between therapy response and the percentage of positive tumour cells with neuroendocrine differentiation (p<0.05). The one-year and two-year follow-up survival period in patients with neuroendocrine expression was 64% (without expression 28%; p<0.001) and 30% (p=0.000). Conclusion. Tissue expression of neuroendocrine markers influences greatly a therapeutic response in patients with advanced stage of NSCLC. Better therapeutic response was recorded in patients with positive expression of neuroendocrine markers and higher percentage of positive tumour cells. Median survival time is higher in patients in III or IV stage of NSCLC, when neuroendocrine markers are expressed." @default.
- W1998318442 created "2016-06-24" @default.
- W1998318442 creator A5006216473 @default.
- W1998318442 creator A5042279259 @default.
- W1998318442 creator A5080628145 @default.
- W1998318442 date "2010-01-01" @default.
- W1998318442 modified "2023-09-25" @default.
- W1998318442 title "The value of neuroendocrine markers for response to therapy and survival in patients with advanced non-small cell lung cancer" @default.
- W1998318442 cites W1985385147 @default.
- W1998318442 cites W1988840595 @default.
- W1998318442 cites W1994635499 @default.
- W1998318442 cites W2020830322 @default.
- W1998318442 cites W2028837881 @default.
- W1998318442 cites W2033266412 @default.
- W1998318442 cites W2040845724 @default.
- W1998318442 cites W2044328190 @default.
- W1998318442 cites W2074971086 @default.
- W1998318442 cites W2078087226 @default.
- W1998318442 cites W2079145144 @default.
- W1998318442 cites W2133040355 @default.
- W1998318442 cites W2145653040 @default.
- W1998318442 cites W4248649728 @default.
- W1998318442 doi "https://doi.org/10.2298/sarh1002037p" @default.
- W1998318442 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/20422910" @default.
- W1998318442 hasPublicationYear "2010" @default.
- W1998318442 type Work @default.
- W1998318442 sameAs 1998318442 @default.
- W1998318442 citedByCount "1" @default.
- W1998318442 countsByYear W19983184422020 @default.
- W1998318442 crossrefType "journal-article" @default.
- W1998318442 hasAuthorship W1998318442A5006216473 @default.
- W1998318442 hasAuthorship W1998318442A5042279259 @default.
- W1998318442 hasAuthorship W1998318442A5080628145 @default.
- W1998318442 hasBestOaLocation W19983184421 @default.
- W1998318442 hasConcept C121608353 @default.
- W1998318442 hasConcept C126322002 @default.
- W1998318442 hasConcept C142724271 @default.
- W1998318442 hasConcept C143998085 @default.
- W1998318442 hasConcept C146357865 @default.
- W1998318442 hasConcept C151730666 @default.
- W1998318442 hasConcept C188618488 @default.
- W1998318442 hasConcept C204232928 @default.
- W1998318442 hasConcept C2776256026 @default.
- W1998318442 hasConcept C2776694085 @default.
- W1998318442 hasConcept C2779634585 @default.
- W1998318442 hasConcept C2780192828 @default.
- W1998318442 hasConcept C2780341458 @default.
- W1998318442 hasConcept C2781413609 @default.
- W1998318442 hasConcept C71924100 @default.
- W1998318442 hasConcept C77231918 @default.
- W1998318442 hasConcept C86803240 @default.
- W1998318442 hasConcept C90924648 @default.
- W1998318442 hasConceptScore W1998318442C121608353 @default.
- W1998318442 hasConceptScore W1998318442C126322002 @default.
- W1998318442 hasConceptScore W1998318442C142724271 @default.
- W1998318442 hasConceptScore W1998318442C143998085 @default.
- W1998318442 hasConceptScore W1998318442C146357865 @default.
- W1998318442 hasConceptScore W1998318442C151730666 @default.
- W1998318442 hasConceptScore W1998318442C188618488 @default.
- W1998318442 hasConceptScore W1998318442C204232928 @default.
- W1998318442 hasConceptScore W1998318442C2776256026 @default.
- W1998318442 hasConceptScore W1998318442C2776694085 @default.
- W1998318442 hasConceptScore W1998318442C2779634585 @default.
- W1998318442 hasConceptScore W1998318442C2780192828 @default.
- W1998318442 hasConceptScore W1998318442C2780341458 @default.
- W1998318442 hasConceptScore W1998318442C2781413609 @default.
- W1998318442 hasConceptScore W1998318442C71924100 @default.
- W1998318442 hasConceptScore W1998318442C77231918 @default.
- W1998318442 hasConceptScore W1998318442C86803240 @default.
- W1998318442 hasConceptScore W1998318442C90924648 @default.
- W1998318442 hasIssue "1-2" @default.
- W1998318442 hasLocation W19983184421 @default.
- W1998318442 hasLocation W19983184422 @default.
- W1998318442 hasOpenAccess W1998318442 @default.
- W1998318442 hasPrimaryLocation W19983184421 @default.
- W1998318442 hasRelatedWork W1988058345 @default.
- W1998318442 hasRelatedWork W2027807541 @default.
- W1998318442 hasRelatedWork W2053551177 @default.
- W1998318442 hasRelatedWork W2071092698 @default.
- W1998318442 hasRelatedWork W2101132824 @default.
- W1998318442 hasRelatedWork W2285926448 @default.
- W1998318442 hasRelatedWork W2321860123 @default.
- W1998318442 hasRelatedWork W2361895373 @default.
- W1998318442 hasRelatedWork W2383078203 @default.
- W1998318442 hasRelatedWork W2397016644 @default.
- W1998318442 hasVolume "138" @default.
- W1998318442 isParatext "false" @default.
- W1998318442 isRetracted "false" @default.
- W1998318442 magId "1998318442" @default.
- W1998318442 workType "article" @default.